Skip to Content Skip to Content

Health Sciences

Reset All Filters
2007 Results
Research Team from Penn Receives Vaccine Industry Excellence Award

Research Team from Penn Receives Vaccine Industry Excellence Award

The laboratory of David Weiner, PhD, a professor of Pathology and Laboratory Medicine at the Perelman School of Medicine at the University of Pennsylvania, received the 2015 V

Karen Kreeger

Penn Study Shows Risk of Breast and Ovarian Cancer May Differ By Type of BRCA1, BRCA2 Mutation

Penn Study Shows Risk of Breast and Ovarian Cancer May Differ By Type of BRCA1, BRCA2 Mutation

In a study involving more than 31,000 women with cancer-causing mutations in the BRCA1 or BRCA2 genes, researchers at the Basser Center for BRCA, the Abramson Cancer Center, and the Perelman School of Medicine at the University of Pennsylvania, identified mutations that are associated with significantly different risks of breast and ovarian cancers.

Katie Delach

Penn-Rochester Study Identifies a Novel Way to Deliver Drugs to Control Dental Plaque

Penn-Rochester Study Identifies a Novel Way to Deliver Drugs to Control Dental Plaque

Therapeutic agents intended to reduce dental plaque and prevent tooth decay are often removed by saliva and the act of swallowing before they can take effect. But a team of researchers has developed a way to keep the drugs from being washed away.

Katherine Unger Baillie , Peter Iglinski

Penn Celebrates National Public Health Week

Penn Celebrates National Public Health Week

Penn's health schools are celebrating National Public Health Week by featuring stories that highlight public health efforts across the University. Follow along on Twitter at ‪#‎PennOneHealth‬. ***

Katherine Unger Baillie

HIV Patients Experience Better Kidney Transplant Outcomes than Hepatitis C Patients, According to Penn Study

HIV Patients Experience Better Kidney Transplant Outcomes than Hepatitis C Patients, According to Penn Study

HIV (human immunodeficiency virus)-positive kidney transplant patients experienced superior outcomes when compared to kidney transplant patients with Hepatitis C and those infected with both HIV and Hepatitis C, according to a study led by researchers at the Perelman School of Medicine at theUniversity of Pennsylvania and published online in Kidney International.

Anna Duerr

Odds of Reversing ICU Patients' Prior Preferences to Forgo Life-Sustaining Therapies Vary Widely Across the U.S., according to Penn Study

Odds of Reversing ICU Patients' Prior Preferences to Forgo Life-Sustaining Therapies Vary Widely Across the U.S., according to Penn Study

Intensive care units across the United States vary widely in how they manage the care of patients who have set preexisting limits on life-sustaining therapies, such as authorizing do-not-resuscitate (DNR) orders and prohibiting interventions such as feeding tubes or dialysis, according to new research from the Perelman School of Medicine at the University of Pennsylvania. Their work is published in the current issue of JAMA Internal Medicine.

Lee-Ann Donegan